MDM2-p53 Pathway Status in Clinical Samples of Well-Differentiated and Dedifferentiated Liposarcoma.

被引：0
|
作者：
Kumagai, A.
Motoi, T.
Yoshida, A.
Imamura, T.
Fukusato, T.
机构：
[1] Teikyo Univ, Sch Med, Tokyo 173, Japan
[2] Univ Tokyo, Tokyo, Japan
[3] Teikyo Univ Hosp, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
56
引用
收藏
页码：17A / 17A
页数：1
相关论文
共 50 条
  • [31] Exploring the role of MDM2-TP53 pathway and ATM in regulation of ferroptosis in dedifferentiated liposarcoma
    Yen, Chueh-Chuan
    Chen, San-Chi
    Chen, Chih-Hsueh
    Wang, Jir-You
    Chen, Chao-Ming
    Wu, Po-Kuei
    Yang, Muh-Hwa
    Chen, Wei-Ming
    CANCER RESEARCH, 2024, 84 (06)
  • [32] MDM2 Copy Numbers in Well Differentiated and Dedifferentiated Liposarcoma: Where Do We Draw the Line?
    Ware, P.
    Snow, A.
    Pettenati, M.
    Qasem, S.
    MODERN PATHOLOGY, 2012, 25 : 22A - 22A
  • [33] Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2
    Garcia-Cano, Jesus
    Sanchez-Tena, Susana
    Sala-Gaston, Joan
    Figueras, Agnes
    Vinals, Francesc
    Bartrons, Ramon
    Ventura, Francesc
    Rosa, Jose Luis
    MOLECULAR ONCOLOGY, 2020, 14 (01) : 69 - 86
  • [34] Diagnostic utility of p16 immunohistochemistry in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma confirmed by fluorescence in situ hybridation
    Kammerer-Jacquet, S. -F.
    Thierry, S.
    Burtin, F.
    Henno, S.
    Le Calve, M.
    Cabillic, F.
    Dugay, F.
    Belaud-Rotureau, M. -A.
    Stock, N.
    VIRCHOWS ARCHIV, 2014, 465 : S17 - S17
  • [35] The Synergistic Effect of Dual Targeting FGFR/FRS2 and IGF1R in Well-differentiated Liposarcoma and Dedifferentiated Liposarcoma
    Lu, Yang
    Peng, Ran
    Jing, Wenyi
    He, Xin
    Qiu, Yan
    Zhang, Hongying
    LABORATORY INVESTIGATION, 2024, 104 (03) : S61 - S61
  • [36] POTENT INHIBITION OF HUMAN LIPOSARCOMA GROWTH AND SURVIVAL BY NOVEL MODULATORS OF THE MDM2-P53 INTERACTION
    Wagner, A. J.
    Zhang, Y. X.
    Sicinska, E.
    Czaplinski, J. T.
    Remillard, S. P.
    Demetri, G. D.
    Weng, S.
    Debussche, L.
    ANNALS OF ONCOLOGY, 2013, 24 : 14 - 14
  • [37] Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors
    Briest, Franziska
    Grass, Irina
    Sedding, Dagmar
    Moebs, Markus
    Christen, Friederike
    Benecke, Joana
    Fuchs, Karolin
    Mende, Stefanie
    Kaemmerer, Daniel
    Saenger, Joerg
    Kunze, Almut
    Geisler, Christina
    Freitag, Helma
    Lewens, Florentine
    Worpenberg, Lina
    Iwaszkiewicz, Sara
    Siegmund, Britta
    Walther, Wolfgang
    Hummel, Michael
    Grabowski, Patricia
    NEUROENDOCRINOLOGY, 2018, 107 (01) : 1 - 23
  • [38] Well-Differentiated Laryngeal/Hypopharyngeal Liposarcoma in the MDM2 Era Report of Three Cases and Literature Review
    Zhu H.
    Sun J.
    Wei S.
    Wang D.
    Brandwein M.
    Head and Neck Pathology, 2017, 11 (2) : 146 - 151
  • [39] Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data
    Wenyi Jing
    Ting Lan
    Yan Qiu
    Ran Peng
    Yang Lu
    Huijiao Chen
    Min Chen
    Xin He
    Chen Chen
    Hongying Zhang
    Diagnostic Pathology, 16
  • [40] Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data
    Jing, Wenyi
    Lan, Ting
    Qiu, Yan
    Peng, Ran
    Lu, Yang
    Chen, Huijiao
    Chen, Min
    He, Xin
    Chen, Chen
    Zhang, Hongying
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
12345